Poplar Point Capital Management LLC 13D and 13G filings for NovaBay Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-10-17 5:10 pm Unchanged | 2025-10-15 | 13D | NovaBay Pharmaceuticals, Inc. NBY | Poplar Point Capital Management LLC | 204,060 17.520% | 0 (Unchanged) | Filing |
| 2025-09-04 7:21 pm Unchanged | 2025-09-03 | 13D | NovaBay Pharmaceuticals, Inc. NBY | Poplar Point Capital Management LLC | 204,060 17.520% | 0 (Unchanged) | Filing |
| 2025-06-04 12:46 pm Purchase | 2025-06-03 | 13D | NovaBay Pharmaceuticals, Inc. NBY | Poplar Point Capital Management LLC | 204,060 17.540% | 9,729 (+5.01%) | Filing |
| 2025-05-15 09:00 am Purchase | 2025-03-31 | 13G | NovaBay Pharmaceuticals, Inc. NBY | Poplar Point Capital Management LLC | 194,331 16.710% | 70,194 (+56.55%) | Filing |
| 2025-02-06 6:30 pm Purchase | 2025-01-31 | 13G | NovaBay Pharmaceuticals, Inc. NBY | Poplar Point Capital Management LLC | 124,137 12.700% | 48,478 (+64.07%) | Filing |
| 2025-01-10 6:06 pm Purchase | 2024-12-31 | 13G | NovaBay Pharmaceuticals, Inc. NBY | Poplar Point Capital Management LLC | 75,659 7.700% | 75,659 (New Position) | Filing |